Does Acute calcium pyrophosphate deposition arthritis doubles fracture risk?
Written By : Isra Zaman
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2023-11-09 03:30 GMT | Update On 2023-11-09 03:30 GMT
Advertisement
At the annual ACR Convergence 2023, researchers unveiled findings from the inaugural study on fractures and calcium pyrophosphate deposition disease (CPPD) , shedding light on a doubled fracture risk in patients with acute calcium pyrophosphate crystal arthritis. Calcium pyrophosphate deposition (CPPD) disease arises when calcium pyrophosphate (CPP) crystals form near cartilage cells, often culminating in joint inflammation, pain, and swelling. Sometimes likened to gout due to clinical similarities, CPPD remains a less understood facet of inflammatory arthritis.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.